Alprolix

Pharma

Sanofi takes $2B hemophilia write-down

It’s been just 16 months since Sanofi closed its Bioverativ buy, but it's already revising its sales projections for one of Bioverativ’s key products.

Carly Helfand Jul 29, 2019 11:51am

How can new launches mimic Keytruda, Harvoni and Opdivo?

Nov 16, 2017 10:23am